Yini namanje eye eye amaconsi ayo

-Delile

• Isetshenziswa kanjani
• Ngubani ongafanele asebenzise
• Imiphumela emibi engaba khona

Kusekhona ukwehla kwamehlo nge-diclofenac ekubunjweni kwayo, yingakho kukhonjisiwe ukunciphisa ukuvuvukala kwengxenye engaphambili yeso leso.

Lokhu kwehla kwamehlo kungasetshenziswa ezimweni ze-conjunctivitis engapheli, i-keratoconjunctivitis, izimo ezibuhlungu zangemva kokuhlukumezeka kwe-cornea kanye ne-conjunctiva, esikhathini sangaphambi nangemva kokuhlinzwa kokuhlinzwa kwamehlo, izilonda eziseceleni ze-corneal, i-photoelectric keratitis ne-episcleritis. Ngaphezu kwalokho, ingasetshenziswa futhi ngokubambisana neminye imithi yokwelapha ukuvuvukala kwe-herpes corneal stroma keratitis.

Kusenjalo umuthi ongathengwa emakhemisi ngentengo engaba ngu-13 reais, lapho kwethulwa incwadi kadokotela.

Isetshenziswa kanjani

Lo muthi kufanele usetshenziswe kuphela emehlweni, kodwa qaphela ukuthi ungathinti ibhodlela ngamehlo akho, ukuze ungangcolisi umkhiqizo osele esitsheni.

Umthamo onconywayo ukwehla okungu-1 esweni elithintekile, ama-4 kuya ku-5 ngosuku noma ngokuqonda kukadokotela. Nakhu ukuthi ungawasebenzisa kanjani kahle amaconsi wamehlo.

Ngubani ongafanele asebenzise

Namanje amaconsi wamehlo akufanele asetshenziswe kubantu abane-aleji kunoma iyiphi into ekhona kwifomula, ngokuhlaselwa yi-asthma, isifuba noma i-rhinitis ebangelwa yimithi engeyona i-steroidal anti-inflammatory.

Ngaphezu kwalokho, kuyaphikiswa futhi kwabesifazane abakhulelwe nabancelisayo nezingane ezingaphansi kweminyaka eyi-14, ngaphandle kwamacala esifo esingalapheki samathambo esencane.

Imiphumela emibi engaba khona

Lo muthi uvame ukubekezelelwa kahle, kepha kwabanye abantu umuzwa ovuthayo noma ukucasuka okudlulayo kungenzeka ngokushesha ngemuva kokufakwa.